PAMU
AUPH icon

Pictet Asset Management (UK)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Pictet Asset Management (UK)’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$28.1M Sell
2,170,394
-1,636,862
-43% -$20.9M 0.03% 452
2021
Q1 		$49.4M Buy
3,807,256
+181,262
+5% +$2.63M 0.06% 331
2020
Q4 		$50.1M Sell
3,625,994
-130,662
-3% -$1.9M 0.07% 311
2020
Q3 		$55.3M Buy
3,756,656
+1,600,575
+74% +$23.2M 0.09% 257
2020
Q2 		$35M Buy
2,156,081
+540,199
+33% +$8.65M 0.06% 305
2020
Q1 		$23.4M Buy
+1,615,882
New +$28.5M 0.05% 342

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Pictet Asset Management (UK)'s AUPH Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Aurinia Pharmaceuticals (AUPH) stake by 43% in Q2 2021, selling an estimated $20.9M and leaving 2,170,394 shares worth $28.1M. The position accounts for 0.03% of the portfolio, ranked #452.

Pictet Asset Management (UK) first reported a position in AUPH in Q1 2020 and has held it in 6 quarters since. The position peaked at $55.3M in Q3 2020. 167 funds tracked by Wall St. Rank hold AUPH as of Q2 2021.

  • Pictet Asset Management (UK) held 2,170,394 shares of Aurinia Pharmaceuticals worth $28.1M as of Q2 2021.
  • Pictet Asset Management (UK) sold 1,636,862 Aurinia Pharmaceuticals shares in Q2 2021, an estimated $20.9M.
  • Aurinia Pharmaceuticals made up 0.03% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #452 holding.
  • Pictet Asset Management (UK) first reported a position in Aurinia Pharmaceuticals in Q1 2020 and has held it in 6 quarters since.
  • Pictet Asset Management (UK)'s Aurinia Pharmaceuticals position peaked at $55.3M in Q3 2020.
  • 167 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.